Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura Kulik(Northwestern University), Riad Salem(Northwestern University), Bassel Atassi(Society of Interventional Radiology), Brian I. Carr(University of Pittsburgh), Robert J. Lewandowski(Society of Interventional Radiology), Mary F. Mulcahy(Northwestern University), Reed A. Omary(Vanderbilt University), Robert K. Ryu(University of Colorado Anschutz Medical Campus), Michaël Abécassis(University of Arizona), Albert A. Nemcek(Northwestern Medicine), Vanessa L. Gates(Society of Interventional Radiology), Kent T. Sato(Society of Interventional Radiology), Al B. Benson(Northwestern University)
Cited by 620
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k